H1 2026 report
Przychody Grupy wzrosły +10,7% r/r do 50,2 mln PLN w I półroczu 2026 roku, z przyspieszeniem do +19,3% r/r w samym II kwartale, napędzane rynkiem polskim (+29% r/r) i segmentem immunochemicznym (+20,6% r/r).
Sentiment
●●●●●●
CRM
H1 2026 report
Revenue
45.38 m PLN
— YoY
Net income
-1.95 m PLN
— YoY
EBITDA
1.33 m PLN
— YoY
Gross margin
39.93%
— YoY
Summary
Investment thesis
- Strata operacyjna zmniejszyła się r/r (-0,5 mln PLN vs -1,6 mln PLN), a w II kwartale Grupa osiągnęła dodatni EBIT (0,6 mln PLN) — sygnał poprawy efektywności operacyjnej.
- Biegły rewident zamieścił w raporcie z przeglądu akapit o istotnej niepewności dotyczącej kontynuacji działalności — skumulowana strata jednostki dominującej przewyższa kapitał zapasowy/rezerwowy i 1/3 kapitału zakładowego.
- Płynność Grupy wspiera pomostowe finansowanie 5 mln PLN pozyskane w czerwcu 2026 roku od największego akcjonariusza (TOTAL FIZ, 19% akcji) w formie obligacji zabezpieczonych na nieruchomości przeznaczonej do sprzedaży — nie z własnej działalności operacyjnej.
- Grupa ma istotną (18,7% przychodów) i ryzykowną ekspozycję na rynki Rosji, Białorusi i Ukrainy, z rosnącym ryzykiem sankcji eksportowych na analizatory diagnostyczne.
Read the full analysis
Financial data is open to everyone. The full analysis — management verdict, commentary, risks, and the full narrative — is available after you sign up or log in.
Financials
BETA
CRM · H1 2026
| Metric | H1 2026 | H1 2025 | Δ YoY | YTD 2026 | Δ YoY | Value type | Segment | Conf. |
|---|---|---|---|---|---|---|---|---|
| Revenue | 22.6 | — | — | 45.38 | — | reported | — | 1.00 |
| Gross profit | 8.55 | — | — | 18.12 | — | reported | — | 1.00 |
| EBITDA | -0.14 | — | — | 1.33 | — | derived | — | 0.85 |
| EBIT | -1.63 | — | — | -1.55 | — | reported | — | 1.00 |
| EBT | -1.7 | — | — | -1.7 | — | reported | — | 1.00 |
| Net income | -2.53 | — | — | -1.95 | — | reported | — | 1.00 |
| EPS (basic) (PLN) | -0.03 | — | — | -0.02 | — | reported | — | 1.00 |
| EPS (diluted) (PLN) | -0.03 | — | — | -0.03 | — | reported | — | 1.00 |
| D&A | 2.89 | — | — | 2.89 | — | reported | — | 1.00 |
| Income tax | 0.25 | — | — | 0.25 | — | reported | — | 1.00 |
| Shares (basic) (m units) | 84.21 | — | — | — | — | reported | — | 1.00 |
| Gross margin | 37.85% | — | — | 39.93% | — | derived | — | 0.95 |
| EBITDA margin | 2.94% | — | — | 2.94% | — | derived | — | 0.95 |
| EBIT margin | -7.2% | — | — | -3.42% | — | derived | — | 0.95 |
| Net margin | -4.31% | — | — | -4.31% | — | derived | — | 0.90 |
| Cash | 4.65 | — | — | — | — | reported | — | 1.00 |
| Total debt | 10.25 | — | — | — | — | reported | — | 0.90 |
| Net debt | 5.59 | — | — | — | — | derived | — | 0.85 |
| Equity | 46.35 | — | — | — | — | reported | — | 1.00 |
| Total assets | 88.18 | — | — | — | — | reported | — | 1.00 |
| Working capital | 7.72 | — | — | — | — | derived | — | 0.90 |
| Current assets | 40.66 | — | — | — | — | reported | — | 1.00 |
| Current liabilities | 32.95 | — | — | — | — | reported | — | 1.00 |
| Non-current liabilities | 8.88 | — | — | — | — | reported | — | 1.00 |
| Inventory | 17.92 | — | — | — | — | reported | — | 1.00 |
| Trade receivables | 15.2 | — | — | — | — | reported | — | 0.85 |
| Trade payables | 16.77 | — | — | — | — | reported | — | 0.85 |
| Goodwill | 21.69 | — | — | — | — | reported | — | 0.95 |
| Tangible equity | 24.67 | — | — | — | — | derived | — | 0.85 |
| CFO | -0.99 | — | — | -0.99 | — | reported | — | 1.00 |
| CapEx | 1 | — | — | 1 | — | reported | — | 0.95 |
| FCF | -1.99 | — | — | -1.99 | — | derived | — | 0.95 |
| FCF conversion | -149.33% | — | — | -149.33% | — | derived | — | 0.90 |
| CFO conversion | -74.14% | — | — | -74.14% | — | derived | — | 0.95 |
| Current ratio | 1.23x | — | — | — | — | derived | — | 0.95 |
| Quick ratio | 0.69x | — | — | — | — | derived | — | 0.95 |
| Cash ratio | 0.14x | — | — | — | — | derived | — | 0.95 |
| Debt / equity | 0.22x | — | — | — | — | derived | — | 0.85 |
| Debt / assets | 0.12x | — | — | — | — | derived | — | 0.85 |
| Net debt / equity | 0.12x | — | — | — | — | derived | — | 0.80 |
| Revenue growth (YoY) | 19.27% | — | — | 10.65% | — | derived | — | 0.95 |
| EBITDA growth (YoY) | 83.58% | — | — | 83.58% | — | derived | — | 0.90 |
| EBIT growth (YoY) | 137.99% | — | — | 64.75% | — | derived | — | 0.90 |
| Net income growth (YoY) | 96.56% | — | — | -22.13% | — | derived | — | 0.90 |
| EPS growth (YoY) | 96.67% | — | — | -21.74% | — | derived | — | 0.90 |
| FCF growth (YoY) | -138.35% | — | — | -138.35% | — | derived | — | 0.85 |
| Gross margin Δ (YoY) | 4.35 pp | — | — | 0.75 pp | — | derived | — | 0.90 |
| EBITDA margin Δ (YoY) | 1.94 pp | — | — | 1.94 pp | — | derived | — | 0.90 |
| EBIT margin Δ (YoY) | 9.49 pp | — | — | 2.33 pp | — | derived | — | 0.90 |
| Net margin Δ (YoY) | -0.44 pp | — | — | -0.44 pp | — | derived | — | 0.90 |
H1 2026 · Δ YoY
Revenue
22.6
—
22.6
—
- H1 2025
- —
- YTD 2026
- 45.38
- Δ YoY
- —
Gross profit
8.55
—
8.55
—
- H1 2025
- —
- YTD 2026
- 18.12
- Δ YoY
- —
EBITDA
-0.14
—
-0.14
—
- H1 2025
- —
- YTD 2026
- 1.33
- Δ YoY
- —
EBIT
-1.63
—
-1.63
—
- H1 2025
- —
- YTD 2026
- -1.55
- Δ YoY
- —
EBT
-1.7
—
-1.7
—
- H1 2025
- —
- YTD 2026
- -1.7
- Δ YoY
- —
Net income
-2.53
—
-2.53
—
- H1 2025
- —
- YTD 2026
- -1.95
- Δ YoY
- —
EPS (basic)
(PLN)
-0.03
—
-0.03
—
- H1 2025
- —
- YTD 2026
- -0.02
- Δ YoY
- —
EPS (diluted)
(PLN)
-0.03
—
-0.03
—
- H1 2025
- —
- YTD 2026
- -0.03
- Δ YoY
- —
D&A
2.89
—
2.89
—
- H1 2025
- —
- YTD 2026
- 2.89
- Δ YoY
- —
Income tax
0.25
—
0.25
—
- H1 2025
- —
- YTD 2026
- 0.25
- Δ YoY
- —
Shares (basic)
(m units)
84.21
—
84.21
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Gross margin
37.85%
—
37.85%
—
- H1 2025
- —
- YTD 2026
- 39.93%
- Δ YoY
- —
EBITDA margin
2.94%
—
2.94%
—
- H1 2025
- —
- YTD 2026
- 2.94%
- Δ YoY
- —
EBIT margin
-7.2%
—
-7.2%
—
- H1 2025
- —
- YTD 2026
- -3.42%
- Δ YoY
- —
Net margin
-4.31%
—
-4.31%
—
- H1 2025
- —
- YTD 2026
- -4.31%
- Δ YoY
- —
Cash
4.65
—
4.65
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Total debt
10.25
—
10.25
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net debt
5.59
—
5.59
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Equity
46.35
—
46.35
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Total assets
88.18
—
88.18
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Working capital
7.72
—
7.72
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current assets
40.66
—
40.66
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Current liabilities
32.95
—
32.95
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Non-current liabilities
8.88
—
8.88
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Inventory
17.92
—
17.92
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Trade receivables
15.2
—
15.2
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Trade payables
16.77
—
16.77
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Goodwill
21.69
—
21.69
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Tangible equity
24.67
—
24.67
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
CFO
-0.99
—
-0.99
—
- H1 2025
- —
- YTD 2026
- -0.99
- Δ YoY
- —
CapEx
1
—
1
—
- H1 2025
- —
- YTD 2026
- 1
- Δ YoY
- —
FCF
-1.99
—
-1.99
—
- H1 2025
- —
- YTD 2026
- -1.99
- Δ YoY
- —
FCF conversion
-149.33%
—
-149.33%
—
- H1 2025
- —
- YTD 2026
- -149.33%
- Δ YoY
- —
CFO conversion
-74.14%
—
-74.14%
—
- H1 2025
- —
- YTD 2026
- -74.14%
- Δ YoY
- —
Current ratio
1.23x
—
1.23x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Quick ratio
0.69x
—
0.69x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Cash ratio
0.14x
—
0.14x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Debt / equity
0.22x
—
0.22x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Debt / assets
0.12x
—
0.12x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Net debt / equity
0.12x
—
0.12x
—
- H1 2025
- —
- YTD 2026
- —
- Δ YoY
- —
Revenue growth (YoY)
19.27%
—
19.27%
—
- H1 2025
- —
- YTD 2026
- 10.65%
- Δ YoY
- —
EBITDA growth (YoY)
83.58%
—
83.58%
—
- H1 2025
- —
- YTD 2026
- 83.58%
- Δ YoY
- —
EBIT growth (YoY)
137.99%
—
137.99%
—
- H1 2025
- —
- YTD 2026
- 64.75%
- Δ YoY
- —
Net income growth (YoY)
96.56%
—
96.56%
—
- H1 2025
- —
- YTD 2026
- -22.13%
- Δ YoY
- —
EPS growth (YoY)
96.67%
—
96.67%
—
- H1 2025
- —
- YTD 2026
- -21.74%
- Δ YoY
- —
FCF growth (YoY)
-138.35%
—
-138.35%
—
- H1 2025
- —
- YTD 2026
- -138.35%
- Δ YoY
- —
Gross margin Δ (YoY)
4.35 pp
—
4.35 pp
—
- H1 2025
- —
- YTD 2026
- 0.75 pp
- Δ YoY
- —
EBITDA margin Δ (YoY)
1.94 pp
—
1.94 pp
—
- H1 2025
- —
- YTD 2026
- 1.94 pp
- Δ YoY
- —
EBIT margin Δ (YoY)
9.49 pp
—
9.49 pp
—
- H1 2025
- —
- YTD 2026
- 2.33 pp
- Δ YoY
- —
Net margin Δ (YoY)
-0.44 pp
—
-0.44 pp
—
- H1 2025
- —
- YTD 2026
- -0.44 pp
- Δ YoY
- —